Frequency Therapeutics

Chris Loose, Ph.D. is the Co-founder and Chief Scientific Officer of Frequency Therapeutics. Dr. Loose co-founded Semprus BioSciences and served as Chief Technology Officer through the company’s acquisition in 2012. In 2011, he was awarded the inaugural Peter Strauss Entrepreneurial Award from the Hertz Foundation. He is currently an Adjunct Associate Professor of Urology in the Yale School of Medicine.